• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Pulmonary kinetics of fentanyl and alfentanil in surgical patients.

作者信息

Taeger K, Weninger E, Schmelzer F, Adt M, Franke N, Peter K

机构信息

Institut fuer Anaesthesiologie, Klinikum Grosshadern der Ludwig-Maximilians-Universitaet Muenchen, W. Germany.

出版信息

Br J Anaesth. 1988 Oct;61(4):425-34. doi: 10.1093/bja/61.4.425.

DOI:10.1093/bja/61.4.425
PMID:2903758
Abstract

The pulmonary kinetics of fentanyl and alfentanil were studied quantitatively in two groups of five and six surgical patients, respectively, after the induction of anaesthesia. A mixture of one of the opioids and indocyanine green was administered as a bolus. From measurements of the concentrations of the dye in plasma and the opioids in blood, central blood volume and the amount of drug which passed through the pulmonary circulation were calculated. The pulmonary release of fentanyl and alfentanil was calculated from the arterial-mixed venous blood concentration differences. Fentanyl 43.0-86.9% (median 70.9%) and 35.9-79.8% of alfentanil (median 58.6%) were sequestered by the lung on first passage of the opioid-containing blood through the pulmonary capillaries. During the following 14 min, fentanyl was released, apparently from two binding sites (T1/2fast: 0.22 (0.16-0.27) min; T1/2slow: 5.78 (3.65-13.86) min). Initially, there was a rapid release of alfentanil (T1/2: 0.28 (0.08-0.51) min). However, 1-3 min after injection, the arterial-mixed venous blood concentration differences of alfentanil disappeared, although considerable amounts of drug were still present in the lung of five of the six patients studied. It may be expected that a temporary pulmonary sequestration of fentanyl and alfentanil has considerable impact on the time course of their pharmacological effects, on the time necessary to reach their maximum effect and on the intensity and (in case of fentanyl) the duration of these effects.

摘要

相似文献

1
Pulmonary kinetics of fentanyl and alfentanil in surgical patients.
Br J Anaesth. 1988 Oct;61(4):425-34. doi: 10.1093/bja/61.4.425.
2
Pharmacokinetics of human cerebral opioid extraction: a comparative study on sufentanil, fentanyl, and alfentanil in a patient after severe head injury.人脑阿片类药物提取的药代动力学:重度颅脑损伤患者中舒芬太尼、芬太尼和阿芬太尼的对比研究
Anesthesiology. 2000 Jun;92(6):1559-67. doi: 10.1097/00000542-200006000-00012.
3
Binding of fentanyl and alfentanil to the extracorporeal circuit.芬太尼和阿芬太尼与体外循环回路的结合。
Acta Anaesthesiol Scand. 1987 Nov;31(8):706-10. doi: 10.1111/j.1399-6576.1987.tb02649.x.
4
The pharmacokinetics of alfentanil (R39209): a new opioid analgesic.阿芬太尼(R39209)的药代动力学:一种新型阿片类镇痛药。
Anesthesiology. 1982 Dec;57(6):439-43. doi: 10.1097/00000542-198212000-00002.
5
Clinical pharmacokinetics of alfentanil, fentanyl and sufentanil. An update.阿芬太尼、芬太尼和舒芬太尼的临床药代动力学。最新进展。
Clin Pharmacokinet. 1996 Oct;31(4):275-92. doi: 10.2165/00003088-199631040-00004.
6
Uptake of sufentanil, alfentanil and morphine in the lungs of patients about to undergo coronary artery surgery.
Br J Anaesth. 1992 Apr;68(4):370-5. doi: 10.1093/bja/68.4.370.
7
Comparative pharmacokinetics of fentanyl and alfentanil.芬太尼与阿芬太尼的比较药代动力学
Br J Anaesth. 1982 Aug;54(8):871-7. doi: 10.1093/bja/54.8.871.
8
Follicular fluid levels of midazolam, fentanyl, and alfentanil during transvaginal oocyte retrieval.
Fertil Steril. 1995 Nov;64(5):1003-7.
9
Continuous infusion of fentanyl or alfentanil for coronary artery surgery. Plasma opiate concentrations, haemodynamics and postoperative course.冠状动脉手术中芬太尼或阿芬太尼的持续输注。血浆阿片类药物浓度、血流动力学及术后病程。
Br J Anaesth. 1986 Nov;58(11):1252-9. doi: 10.1093/bja/58.11.1252.
10
Pharmacokinetics of alfentanil in man.阿芬太尼在人体中的药代动力学。
Anesth Analg. 1982 Aug;61(8):657-61.

引用本文的文献

1
Pharmacokinetics of non-intravenous formulations of fentanyl.芬太尼非胃肠外制剂的药代动力学。
Clin Pharmacokinet. 2013 Jan;52(1):23-36. doi: 10.1007/s40262-012-0016-7.
2
Determination of the distribution volume that can be used to calculate the intravenous loading dose.用于计算静脉注射负荷剂量的分布容积的测定。
Clin Pharmacokinet. 1998 Jul;35(1):1-7. doi: 10.2165/00003088-199835010-00001.
3
A recirculatory model of the pulmonary uptake and pharmacokinetics of lidocaine based on analysis of arterial and mixed venous data from dogs.
基于对犬动脉和混合静脉数据的分析建立的利多卡因肺摄取和药代动力学的再循环模型。
J Pharmacokinet Biopharm. 1997 Apr;25(2):169-90. doi: 10.1023/a:1025780012960.
4
Pulmonary distribution of alfentanil and sufentanil studied with system dynamics analysis.
J Pharmacokinet Biopharm. 1996 Apr;24(2):197-218. doi: 10.1007/BF02353489.
5
Comparative physiological pharmacokinetics of fentanyl and alfentanil in rats and humans based on parametric single-tissue models.基于参数化单组织模型的大鼠和人类中芬太尼与阿芬太尼的比较生理药代动力学
J Pharmacokinet Biopharm. 1994 Oct;22(5):381-410. doi: 10.1007/BF02353862.
6
Respiratory mechanical properties during fentanyl and alfentanil anaesthesia.
Can J Anaesth. 1992 May;39(5 Pt 1):458-65. doi: 10.1007/BF03008710.